Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Upadacitinib improved multiple immune-related conditions in one patient.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Apremilast may help treat hair loss in alopecia areata.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Betulinic acid can help treat hepatitis C by stopping virus replication.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Remembering to take PrEP is the main challenge, and urine monitoring is a preferred adherence method.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Avacopan may cause unexpected side effects, so early monitoring is important.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.